Pharm Practice Exam 3

13 Questions | Total Attempts: 73

SettingsSettingsSettings
Hypertension Quizzes & Trivia

Airway disease, hypertension, endocarditis, CAD/dyslipidemia, heart failure, antiarrhythmics, anemias, DVT/thromboembolism


Questions and Answers
  • 1. 
    A patient complains that his asthma symptoms are awakening him two or three times a week.  When asked he states he uses his SABA about daily.  Which of the following treatments would be appropriate?
    • A. 

      SABA PRN

    • B. 

      SABA PRN and low dose ICS

    • C. 

      SABA PRN, low dose ICS and LABA

    • D. 

      SABA PRN, medium dose ICS and LABA

    • E. 

      SABA PRN, high dose ICS and LABA, consider omalizumab

  • 2. 
    Which EPR-3 stage of asthma describes the patient in question 1?
    • A. 

      Intermittent

    • B. 

      Mild persistent

    • C. 

      Moderate persistent

    • D. 

      Severe persistent

  • 3. 
    If the patient's asthma is well controlled, which of the following is false?
    • A. 

      Symptoms occur less than 2 days per week

    • B. 

      FEV1 is greater than 80% predicted or at personal best

    • C. 

      There is no interference with normal activities

    • D. 

      Nighttime awakenings occur less than twice per week

  • 4. 
    Which of the following is not a short-acting Beta-2 agonist?
    • A. 

      Theophylline

    • B. 

      Levalbuterol

    • C. 

      Albuterol

    • D. 

      Salmeterol

  • 5. 
    Which of the following drugs works by inhibiting phosphodiesterase, preventing the breakdown of cAMP, causing smooth muscle relaxation?
    • A. 

      Beta-2 agonists

    • B. 

      Methylxanthines

    • C. 

      Anticholinergics

    • D. 

      Corticosteroids

  • 6. 
    Which will decrease the metabolism of theophylline?
    • A. 

      Smoking

    • B. 

      Phenytoin

    • C. 

      Oral contraceptives

    • D. 

      Erythromycin

  • 7. 
    What is the therapeutic range of methylxanthine?
    • A. 

      1-10 mg/dL

    • B. 

      5-15 mg/dL

    • C. 

      1-15 mg/dL

    • D. 

      5-20 mg/dL

  • 8. 
    Which of the following is not an adverse effect of methylxanthine?
    • A. 

      CNS stimulation

    • B. 

      Arrhythmia

    • C. 

      Dysphonia

    • D. 

      Convulsions

  • 9. 
    Which of the following is not in the current guidelines for asthma?
    • A. 

      Beta-2 Agonists

    • B. 

      Anticholinergics

    • C. 

      Corticosteroids

    • D. 

      Leukotriene modifiers

  • 10. 
    Which of the following is true concerning patient education for use of an MDI?
    • A. 

      Pts should put the inhaler in their mouth, especially when using steroids.

    • B. 

      The patient should wait 15-30 seconds between puffs in all inhalers except SABAs

    • C. 

      The patient should press the inhaler while breathing out slowly and deeply

    • D. 

      Patients should hold their breath as they count to ten slowly if possible.

  • 11. 
    Infiltration with basophils is associated with:
    • A. 

      Asthma

    • B. 

      COPD

    • C. 

      Hypertension

    • D. 

      Endocarditis

  • 12. 
    Which is the strongest diuretic?
    • A. 

      Hydrochlorothiazide

    • B. 

      Spironolactone

    • C. 

      Furosemide

    • D. 

      Amiloride

  • 13. 
    Which of the following is a non-selective beta blocker?
    • A. 

      Atenolol

    • B. 

      Propanolol

    • C. 

      Metoprolol

    • D. 

      Acebutolol

Back to Top Back to top